Near-term outlook for Australia's Ansell 'uncertain' - Macquarie

Regis Healthcare

03/08/2023 06:53

** Macquarie says near-term outlook for Australian medical
equipment firm Ansell  ANN.AX  is "uncertain", even as forecasts
capture improved growth from FY25
    ** For biotechnology company CSL  CSL.AX , the brokerage
expects growth on the back of base business recovery despite its
weaker-than-expected FY24 guidance
    ** Expects downside risk to FY23 consensus EPS forecasts for
Ramsay Health Care  RHC.AX  and Sonic Healthcare  SHL.AX  
    ** Sees the potential sale of Ramsay's Asia-focussed joint
venture with Malaysia's Sime Darby will help address its recent
balance sheet concerns
    ** Macquarie says Regis Healthcare's  REG.AX  growth is
driven by positive outlook for residential aged care,
underpinned by favourable industry fundamentals and improved
government funding
    ** YTS, ANN shares are down 15.2%, CSL down 6.8%, RHC down
9.6%, SHL up 15.2% and REG up 19.9% as of last close 
    

 (Reporting by Poonam Behura in Bengaluru)
 ((Poonam.Behura@thomsonreuters.com;))